Sponsor:
Ohio State University Comprehensive Cancer Center
Code:
NCT07216534
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Psychiatric Disorder
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Survey Administration
Virtual Technology Intervention
Virtual Technology Intervention
Virtual Technology Intervention
Brief summary:
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Psychiatric Disorder
Study ID
NCT07216534
Start date
Sep 1, 2026
Status verified date
Jun, 2026
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
32 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
experimental: Arm I (twin followed by opposite streetscape)
experimental: Arm II (opposite followed by twin streetscape)
Interventions
Survey Administration
Virtual Technology Intervention
Virtual Technology Intervention
Virtual Technology Intervention
Primary outcome measure
Central contacts
Locations
Ohio State University Comprehensive Cancer Center
Recruiting
Columbus, Ohio, United States, 43210
Contacts
Jesse Plascak, PhD, MPH
614-293-8024Principal Investigator:
Jesse Plascak, PhD, MPH
Sponsor
Ohio State University Comprehensive Cancer Center
Last update posted
Jun 22, 2026
Last verified
Jun, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center on 2026-06-22.